(Q46689751)

24 December 2017

title

Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients (English)

1 reference

24 December 2017

0 references

1 reference

1 reference

R L Mehta

1

1 reference

24 December 2017

B R McDonald

series ordinal

2

1 reference

24 December 2017

M M Aguilar

series ordinal

3

1 reference

24 December 2017

D M Ward

series ordinal

4

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 November 1990

1 reference

24 December 2017

published in

Kidney International

1 reference

24 December 2017

volume

38

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

976-981

1 reference

24 December 2017

The use of continuous arterlovenous hemodialysis in the management of patients with oliguria associated with multiple organ failure

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Hemorrhage during High-Risk Hemodialysis Using Controlled Heparinization

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Continuous arteriovenous hemofiltration. A report of six months' experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Regional anticoagulation during hemodialysis using citrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Regional anticoagulation: hemodialysis with hypertonic trisodium citrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Solute transport in continuous hemodialysis: a new treatment for acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Continuous arteriovenous hemodiafiltration: an aggressive approach to the management of acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Citrate regional anticoagulation in haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Severe metabolic alkalosis complicating regional citrate hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Hemodynamic effects of intravenously administered sodium citrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Regional citrate anticoagulation for hemodialysis following cardiovascular surgery

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Continuous Arteriovenous Hemofiltration in the Critically Ill Patient

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Heparin-associated thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.300

7 January 2021

Identifiers

DOI

10.1038/KI.1990.300

1 reference

24 December 2017

1 reference

24 December 2017